Brief: Hester Biosciences, IIT Guwahati Partner To Develop Coronavirus Vaccine

Hester Biosciences

29/04/2020 06:21

April 29 (Reuters) - Hester Biosciences Ltd  HEST.NS :
    * IIT GUWAHATI COLLABORATES WITH HESTER BIOSCIENCES LIMITED
TO
DEVELOP VACCINE AGAINST COVID-19
    * VACCINE WILL BE BASED ON RECOMBINANT AVIAN PARAMYXOVIRUS
BASED
VECTOR PLATFORM
    * AGREEMENT BETWEEN PARTIES WAS SIGNED ON 15TH APRIL 2020
    * RECOMBINANT AVIAN PARAMYXOVIRUS-1 WILL BE USED TO EXPRESS
IMMUNOGENIC PROTEIN OF SARS-COV-2
    * RECOMBINANT AVIAN PARAMYXOVIRUS-1 EXPRESSING SARS-COV-2
PROTEIN
COULD BE USED AS VACCINE CANDIDATE FOR FURTHER STUDY
    * IIT GUWAHATI AND CO EXPECT VACCINE TO BE READY BY THE END
OF
THIS YEAR TO START ANIMAL STUDIES
    * SHARES EXTEND GAINS, NOW UP 20% AFTER CO PARTNERS IIT
GUWAHATI
TO DEVELOP CORONAVIRUS VACCINE

Source text for Eikon:  ID:nBSEl4V8y 
Further company coverage:  HEST.NS 

 ((Reuters.Briefs@thomsonreuters.com;))